MAHMOOD FATHOLLAZADEH: Open Payments
NPI 1386711158 · COLTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,050 in 52 payments from 14 companies in 2025. Trend: 2023 $927 · 2024 $814 · 2025 $1,050
Food & beverage: $1,050
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 14 | $411 |
| Collegium Pharmaceutical, Inc. | 13 | $165 |
| ABBVIE INC. | 6 | $123 |
| Saluda Medical Americas, Inc. | 3 | $85 |
| Virtus Pharmaceuticals LLC | 3 | $56 |
| Globus Medical, Inc. | 2 | $37 |
| PFIZER INC. | 2 | $35 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $33 |
| SI-BONE, INC. | 1 | $22 |
| Abbott Laboratories | 1 | $22 |
Products named: WaveWriter Alpha Prime 16, Intracept, Belbuca, Evoke, QULIPTA, LEVORPHANOL TARTRATE, UBRELVY, Senza.
Industry payments across CA — which companies pay providers there.
